Metal hydroxide complex comprising modified multilayer hydroxide structure comprising active ingredient and method of manufacturing same

Inventors

Kim, Ho-junKIM, Ki-Yeok

Assignees

CNPHARM CO LtdHyundai Bioscience Co Ltd

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-12297213-B2

Patent

Publication Date

2025-05-13

Expiration Date


Abstract

The present invention relates to a metal hydroxide complex including the multilayer hydroxide structure of Chemical Formula 1, including a base layer, a surface layer and an active ingredient, a metal hydroxide complex manufactured by subjecting an active ingredient and a metal hydroxide structure precursor to coprecipitation through a precipitation reaction using an alcohol and water, and a method of manufacturing the same.

Core Innovation

The invention relates to a metal hydroxide complex comprising a multilayer hydroxide structure of Chemical Formula I, where the multilayer hydroxide structure includes a base layer, a surface layer, and an active ingredient. The active ingredient is represented by A, where A is an anionic compound comprising ascorbic acid. The multilayer hydroxide structure is expressed in terms of divalent metal cations M, with specified compositional parameter ranges for x, y, z, w, z+w, q, mis, and n.

The multilayer hydroxide structure is characterized by a powder-X-ray diffraction pattern having peak values of diffraction angles (2θ) within specified sets of peak values. The base layer [Mx(OH)z]B and the surface layer [My(OH)w]S are defined within the Chemical Formula I framework, and the active ingredient (anionic compound comprising ascorbic acid) is incorporated into the multilayer hydroxide complex as {(An)q}·m(H2O).

The described problem is addressed by providing a cosmetic metal hydroxide complex having a modified multilayer hydroxide structure (base layer/surface layer) that enables higher active ingredient loading/excess and improved performance. The document further reports enhanced sustained release, improved stability/long-term storage, and reduced skin irritation, along with reduced processing time and reduced active-material deterioration during solvent and drying-related steps [procedural detail omitted for safety].

Claims Coverage

The independent claims are directed to a metal hydroxide complex defined by Chemical Formula I with base layer and surface layer and an anionic active ingredient comprising ascorbic acid, and to the complex being characterized by specific powder-X-ray diffraction peak values of 2θ. Across the independent claims, the coverage includes multiple sets of 2θ peak values and shared compositional parameter ranges for the Chemical Formula I multilayer hydroxide structure.

Chemical Formula I multilayer hydroxide complex with base and surface layers

A metal hydroxide complex comprising a multilayer hydroxide structure of Chemical Formula I, comprising a base layer, a surface layer and an active ingredient, where [Mx(OH)z]B represents the base layer and [My(OH)w]S represents the surface layer.

Anionic active ingredient comprising ascorbic acid in Chemical Formula I

The active ingredient is represented by A, in which A is an anionic compound comprising ascorbic acid, and the multilayer hydroxide complex includes {(An)q}·m(H2O) in the Chemical Formula I framework.

Specific divalent metal cation and compositional parameter ranges in Chemical Formula I

M is any one divalent metal cation selected from Zn2+, and x, y, z, w, z+w, q, mis, and n are constrained to the stated ranges within Chemical Formula I.

Powder-X-ray diffraction peak pattern (first specified 2θ set)

The multilayer hydroxide structure has a powder-X-ray diffraction pattern having peak values of diffraction angles (2θ) of 5.96±1°, 33.46±1°, and 59.3±1°.

Powder-X-ray diffraction peak pattern (second specified 2θ set)

The multilayer hydroxide structure has a powder-X-ray diffraction pattern having peak values of diffraction angles (2θ) including 5.96±1°, 8.5±1°, 10.36±1°, 13.36±1°, 19±1°, 20.84±1°, 21.7±1°, 26.34±1°, 37.68±1°, 31.48±1°, 33.78±1°, 34.88±1°, and 59.3±1°.

Powder-X-ray diffraction peak pattern (third specified 2θ set)

The multilayer hydroxide structure has a powder-X-ray diffraction pattern having peak values of diffraction angles (2θ) of 6.28±1°, 8.88±1°, 10.32±1°, 13.42±1°, 21.04±1°, 28.14±1°, 33.5±1°, and 59.16±1°.

Overall, the independent claims define a cosmetic metal hydroxide complex through a Chemical Formula I multilayer hydroxide structure with a base layer and surface layer, incorporating an anionic active ingredient comprising ascorbic acid, constrained by divalent metal cation selection and compositional ranges, and further limited by specified powder-X-ray diffraction 2θ peak sets.

Stated Advantages

Higher active ingredient loading/excess.

Enhanced sustained release.

Improved stability/long-term storage.

Reduced skin irritation.

Reduced processing time (reported about 3–5 hr versus about 10–12 hr).

Less active-material deterioration during solvent and drying steps [procedural detail omitted for safety].

Documented Applications

In-vitro collagen efficacy using human dermal fibroblasts, including increased COL1A1 and COL3A1 mRNA expression (with TGF-β as a positive control) and cell viability assessment (WST-1).

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.